Celebrates acknowledges faculty, staff, and students at CUMC who receive major research grants or earn prestigious honors, as well as gifts made by donors.
KEYTRUDA is an immunotherapy that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2, helping the immune system to help detect and fight cancer cells.
Funding from the ALS Association and the Tow Foundation will be used by the New York Genome Center to determine the entire genetic sequence of people with ALS who donated their tissues after death.
